Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Bristol-Myers Squibb - Understanding the Emerging Role of I-O in GI Cancers

I-O Studies in CRC: Patient populations of today and tomorrow

Date

27 Sep 2019

Session

Bristol-Myers Squibb - Understanding the Emerging Role of I-O in GI Cancers

Presenters

Miriam Koopman

Authors

M. Koopman

Author affiliations

  • Medical Oncology, University Hospital Utrecht, 3508 GA - Utrecht/NL
More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings